Skip to Main Content

The Effectiveness of Lactobacillus Plantarum (LBP) in Preventing Acute Graft-Versus-Host Disease (GvHD) in Children Undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT)

Conditions

Other Hematopoietic | Pediatrics

Phase III

What is the purpose of this trial?

This randomized phase III trial studies how well Lactobacillus plantarum works in preventing acute graft versus host disease in children undergoing donor stem cell transplant. Lactobacillus plantarum may help prevent the development of gastrointestinal graft versus host disease in children, adolescents, and young adults undergoing donor stem cell transplant.

  • Trial with
    Children's Oncology Group (COG)
  • Start Date
    02/27/2020
  • End Date
    07/31/2023
Trial Image

For more information about this study, contact:

Sharon Huie

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    09/09/2020
  • Study HIC
    #2000026257